Seattle Genetics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
269,264.00
286,758.00
336,802.00
418,147.00
482,250.00
654,700
Cost of Goods Sold (COGS) incl. D&A
21,144.00
29,058.00
37,440.00
42,317.00
54,118.00
88,293
Gross Income
248,120.00
257,700.00
299,362.00
375,830.00
428,132.00
566,407
SG&A Expense
310,981.00
335,063.00
420,312.00
518,555.00
623,933.00
826,405
EBIT
62,861.00
77,363.00
120,950.00
142,725.00
195,801.00
259,998
Unusual Expense
-
-
-
-
33,777.00
7,336
Pretax Income
62,520.00
76,141.00
120,486.00
140,111.00
158,887.00
246,346
Income Tax
-
-
-
-
33,357.00
23,653
Consolidated Net Income
62,520.00
76,141.00
120,486.00
140,111.00
125,530.00
222,693
Net Income
62,520.00
76,141.00
120,486.00
140,111.00
125,530.00
222,693
Net Income After Extraordinaries
62,520.00
76,141.00
120,486.00
140,111.00
125,530.00
222,693
Net Income Available to Common
62,520.00
76,141.00
120,486.00
140,111.00
125,530.00
222,693
EPS (Basic)
0.51
0.62
0.93
1.00
0.88
1.41
Basic Shares Outstanding
121,575.00
123,408.00
129,184.00
140,746.00
143,174.00
157,655
EPS (Diluted)
0.51
0.62
0.93
1.00
0.88
1.41
Diluted Shares Outstanding
121,575.00
123,408.00
129,184.00
140,746.00
143,174.00
157,655
EBITDA
54,246.00
64,873.00
106,445.00
124,691.00
171,532.00
233,966
Non-Operating Interest Income
341.00
1,222.00
464.00
2,614.00
3,137.00
6,316
About Seattle Genetics
View Profile
